Osteoarthritis
Gene therapy approaches for osteoarthritis are focus of review
Published in Gene Therapy Weekly, July 27th, 2006
According to their report, "Osteoarthritis (OA) is common, debilitating, expensive, incurable, and very difficult to treat. Gene transfer to the synovial linings of affected joints is a promising strategy for achieving sustained, therapeutic, intra-articular concentrations of anti-arthritic gene products. This is not reasonably possible with existing, alternative technologies. The present review summarizes progress in achieving direct, in vivo intra-articular gene delivery and expression."
"Numerous non-viral vectors have been...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-07-27)
More Articles from Gene Therapy Weekly
- Antisense Technology
Transferrin receptor-targeted liposome efficiently delivers antisense DNA - Gene Transfer
Adenovirus-mediated gene transfer affects pulmonary artery vascular reactivity - Gene Transfer
Gene transfer achieved using modified cationic liposomes - RNA Research
Polyethylenimine fraction increases transfection efficiency - RNA Research
Small interfering RNA in human cells selectively localizes to target RNA sites - Allergy & Immunology
Defensins participate in innate defense against influenza A virus - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
